Common Contracts

2 similar Supplemental Indenture contracts by PDL Biopharma, Inc.

PDL BIOPHARMA, INC. as Issuer AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee SUPPLEMENTAL INDENTURE Dated as of February 12, 2014 4.00% Convertible Senior Notes due 2018
Supplemental Indenture • February 12th, 2014 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • New York

SUPPLEMENTAL INDENTURE, dated as of February 12, 2014 (this “Supplemental Indenture”), between PDL BioPharma, Inc., a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A, as trustee (the “Trustee”) under the Indenture dated as of February 12, 2014, between the Company and the Trustee (as amended or supplemented from time to time in accordance with the terms thereof, the “Original Indenture”).

AutoNDA by SimpleDocs
PDL BIOPHARMA, INC. as Issuer AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee SUPPLEMENTAL INDENTURE Dated as of May 16, 2011 3.75% Convertible Senior Notes due 2015
Supplemental Indenture • May 16th, 2011 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • New York

SUPPLEMENTAL INDENTURE, dated as of May 16, 2011, between PDL BioPharma, Inc., a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A, as trustee (the “Trustee”) under the Indenture dated as of May 16, 2011, between the Company and the Trustee (as amended or supplemented from time to time in accordance with the terms thereof, the “Original Indenture”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!